Please assess the completion status of the following clinical trial:

Trial Title: Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* were women with singleton pregnancy~* with cephalic presentation~* who had NVD spontaneously or by induction~Exclusion Criteria:~* placenta previa~* placental detachment~* coagulation problems~* previous CS~* macrosomia~* Polyhydramnios~* and uncontrolled asthma

- Gender: FEMALE
- Minimum Age: 10 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Misoprostol (Type: EXPERIMENTAL): 400µg oral misoprostol
- Oxytocin (Type: ACTIVE_COMPARATOR): 20 IU oxytocin

Based on this trial design, predict the completion outcome and termination type (if applicable).